HD Research

HD Research is a clinical research organization (CRO) and site network that specializes in the execution of Phase I-IV clinical trials for the pharmaceutical and biotechnology industries. The company is particularly recognized for its expertise in hepatology and metabolic disorders, with a strong focus on Non-Alcoholic Steatohepatitis (NASH), now referred to as Metabolic Dysfunction-Associated Steatohepatitis (MASH). Operating multiple high-volume sites in Texas and Florida, HD Research provides sponsors with comprehensive services including patient recruitment, trial management, and clinical data collection. The organization plays a critical role in the development of metabolic and liver-directed therapies by leveraging its deep access to specialized patient populations and advanced diagnostic capabilities. It is a key partner for biotech companies advancing next-generation treatments for metabolic syndrome and chronic liver disease.